InvestorsHub Logo
icon url

Investor2014

02/05/22 11:20 AM

#349411 RE: abew4me #349405

“3) All of the naysayers that reject a submission for a NDA using the trial results from Avatar DO NOT have all of the information that the company has. It is pure speculation on their part.”

Excuse me, but speculation is all on those going beyond known facts and that’s a FACT!
icon url

nidan7500

02/05/22 11:53 AM

#349423 RE: abew4me #349405

abew4me

In all seriousness, you should remember that the FDA has a wide range of flexibility to approve the results from the Avatar trial by itself. With an extremely impressive 7-year safety record, the FDA has to weigh the benefits vs. the negatives(?) of approving A2-73 for the Adult Rett population.



Agree. When trial data compiles allowing bigger thoughts for AVXL MOA and CNS disease efficacy then a much more exciting AVXL BO dynamic may develop. Looking forward to developments along this line.

SO MANY DOTS, SO LITTLE TIME.